A panelist discusses how real-world data presented at the 2025 American Academy of Dermatology Annual Meeting (AAD 2025) ...

For over a year, Polly, from Scotland, has been battling painful dermatitis on her hands, and despite her efforts no ...

Using a topical steroid on your face is a common one, but perioral dermatitis can also show up if you’re using thick or oily ...

Recent clinical studies have started showing the benefits of using vitamin B12 cream to help manage dermatitis. Vitamin B12 ...

Many people experience an itchy scalp at some point. It’s usually not a sign of a serious medical condition and can, in most ...

The FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new ...

Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives ...

Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

The FDA approved dupilumab for the treatment of patients 12 years and older with chronic spontaneous urticaria who remain ...

AD is a growing market with an impressive pipeline of new products from current and future players in the field.

Tralokinumab use in patients with head and neck atopic dermatitis was associated with sustained improvements with up to 4 years of treatment.